09:16 AM EDT, 09/19/2025 (MT Newswires) -- Health care stocks were rising pre-bell Friday, with the Health Care Select Sector SPDR Fund ( XLV ) up 0.3% and the iShares Biotechnology ETF (IBB) 0.2% higher.

ARS Pharmaceuticals ( SPRY ) shares were up more than 4% after the company said its nasal spray neffy has received regulatory approval in Japan for the emergency treatment of allergic reactions, including anaphylaxis.

Nuvation Bio ( NUVB ) shares were up nearly 4% after the company said Japan's Ministry of Health, Labour and Welfare has approved its Ibtrozi therapy to treat adult patients with advanced ROS1-positive non-small cell lung cancer.

KalVista Pharmaceuticals ( KALV ) stock was up nearly 3% after the company said the European Commission and the Swiss Agency for Therapeutic Products, Swissmedic, have approved Ekterly for the treatment of hereditary angioedema in adults and adolescents aged 12 years and older.